http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017534347-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2201-0119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-0052
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A63B23-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H5-00
filingDate 2015-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2017534347-A
titleOfInvention Treatment of dry eye and vision enhancer
abstract The dry eye treatment and visual acuity enhancer according to the present invention includes a water eyeglass main body portion in which a saline solution is inserted and a muscle movement of the eyeball is performed in the saline solution in close contact with the user's face, and the water glasses. A saline container that is connected to the upper part of the main body to supply a certain amount of the saline, and is fixed in front of the saline container to guide the user's line of sight to perform eye movement in the saline And a display device on which the eye muscle strengthening program is executed. According to the present invention as described above, the saline container and the water glasses main body are configured to be separable, the hygiene management of the treatment device is easy, and the eye in the physiological saline is in close contact with the water glasses main body. By exercising muscular exercise, it is possible to treat dry eyeball while breathing freely in a relaxed state, and has the effect of improving visual acuity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102560412-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230016870-A
priorityDate 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8721572-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6270467-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451289241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23266

Total number of triples: 26.